Aventis SA (Paris:AVEP.PA - News) and Sanofi-Synthelabo (Paris:SASY.PA - News) shares both gained more than two percent on Monday as speculation of a merger between France’s top two drugmakers mounted.Industry analysts have long tipped the tie-up that would create a $100 billion French champion in a consolidating global pharmaceutical industry.
